确定结性脊髓炎治疗点的优先级:一个多omics门德尔随机化研究
Lingyu Dai1, Lan Xia1, Guannan Su1
1The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Youyi Road 1, Chongqing, 400016, People's Republic of China.
Journal of translational medicine
|December 20, 2024
概括
这项研究使用多omics数据确定了与结性脊髓炎 (AS) 相关的四个基因,并提出了AS治疗的九种潜在药物标. 这些发现提高了对AS遗传机制的理解,并为向治疗提供了新的途径.
科学领域:
- 遗传学和免疫学 遗传学和免疫学
- 药物基因组学 药物基因组学
背景情况:
- 化脊柱炎 (AS) 是一种具有复杂遗传基础的慢性炎症性疾病.
- 在甲基化,表达和蛋白质定量特征位点 (mQTL,eQTL,pQTL) 水平上调查遗传关联对于理解AS病变发生至关重要.
- 识别基因支持的药物标可以推进AS治疗策略.
研究的目的:
- 探索mQTL,eQTL和pQTL与结椎炎 (AS) 的关联.
- 确定AS的基因支持药物标.
- 阐明AS的遗传机制和潜在的治疗点.
主要方法:
- 基于总结数据的门德尔随机化 (SMR) 和贝叶斯共定位分析被用于评估AS和基因之间的因果关系.
- 来自IGAS,FinnGen和英国生物银行的全基因组关联研究 (GWAS) 数据被用于发现和验证.
- 进行了多omics数据集成,蛋白质-蛋白质相互作用 (PPI) 网络分析和分子对接,以识别和验证候选基因和药物点.
主要成果:
- 四个基因 (TNFRSF1A,B3GNT2,ERAP1,FCGR2A) 在不同的监管层面显示出与AS的潜在关联.
- 针对AIF1,TNXB,APOM,B3GNT2,FCGR2A,FCGR2B,IL12B,TNFRSF1A和ERAP1.1,确定了与AS风险的特定蛋白质水平关联.
- 生物信息学分析表明,SMR识别的基因主要参与免疫反应途径.
- 分子对接证实了预测药物与候选蛋白标的稳定结合.
结论:
- 这项研究确定了四个与AS相关的基因,并得到了多基因证据的支持.
- 确定了九种对AS的有前途的药物标,为向治疗提供了潜在的潜力.
- 这些发现有助于理解AS遗传机制,并开发创新的治疗方法.
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


